Navigation Links
Organogenesis CEO Geoff MacKay and COO / CFO Gary Gillheeney Named Ernst & Young Entrepreneur Of The Year(R) 2009 Award Winners in New England
Date:11/10/2009

CANTON, Mass., Nov. 10 /PRNewswire/ -- Organogenesis, Inc., a leading regenerative medicine company, announced that Geoff MacKay, Chief Executive Officer, and Gary Gillheeney, Chief Operating Officer and Chief Financial Officer, received the prestigious Ernst & Young Entrepreneur Of The Year® 2009 Award in the biotechnology category in New England. According to Ernst & Young LLP, the award recognizes outstanding entrepreneurs who are building and leading dynamic, growing businesses. MacKay and Gillheeney were selected by an independent panel of judges.

"This recognition is well deserved," said Dr. Susan Windham-Bannister, President & CEO of the Massachusetts Life Sciences Center. "Organogenesis is a growing company with a terrific future, having established itself as an industry leader in the expanding field of regenerative medicine. We at the Center are proud to have played a role in supporting Organogenesis in its expansion plans in Canton. Congratulations to Geoff, Gary and the entire Organogenesis team on receiving this prestigious honor."

The Ernst & Young Entrepreneur Of The Year awards celebrates its 23rd anniversary this year. The program honors entrepreneurs who have demonstrated excellence in such areas as innovation, financial performance and personal commitment to their businesses and communities.

"We are proud to recognize the achievements of Mr. MacKay and Mr. Gillheeney," said Kristin Keating, Ernst & Young LLP Entrepreneur Of The Year Program Co-Chair for New England. "Winners of the Entrepreneur Of The Year award build leading businesses and contribute significantly to the strength of our region's economy. Their success helps our area grow stronger."

As New England award winners, MacKay and Gillheeney are now eligible for consideration for the Ernst & Young LLP Entrepreneur Of The Year 2009 national program. Award winners in several national categories, as well as the overall national Ernst & Young Entrepreneur Of The Year award winner, will be announced this month at the annual awards gala in Palm Springs, Calif. The awards are the culminating event of the Ernst & Young Strategic Growth Forum, the nation's most prestigious gathering of high-growth, market-leading companies.

About Ernst & Young's Entrepreneur Of The Year® Awards Program

Ernst & Young's Entrepreneur Of The Year® Award is the world's most prestigious business award for entrepreneurs. The award makes a difference through the way it encourages entrepreneurial activity among those with potential and recognizes the contribution of people who inspire others with their vision, leadership and achievement. As the first and only truly global award of its kind, the Ernst & Young Entrepreneur Of The Year® award celebrates those who are building and leading successful, growing and dynamic businesses, recognizing them through regional, national and global awards programs in more than 135 cities in 50 countries.

About Organogenesis, Inc.

Having pioneered the field, Massachusetts based Organogenesis, Inc. is a world leading regenerative medicine company focused in the areas of bio-active wound healing, oral regeneration and bio-surgery. The company's mission is to bring the medical marvel of regenerative medicine products to patients and to standardize their use in everyday medical care. Organogenesis recently established European headquarters located in Switzerland, as well as announced an expansion of its U.S. headquarters. For more information, visit www.organogenesis.com.

SOURCE Organogenesis, Inc.


'/>"/>
SOURCE Organogenesis, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Dr. Damien Bates of Organogenesis Speaks on Regenerative Medicine for Opening Night of TEDMED Conference
2. Organogenesis, Inc. to Develop Regenerative Medicine Therapies for U.S. Military Battlefield Injuries
3. Governor Patrick Announces Life Sciences Initiative Victory With Organogenesis New Headquarters
4. Organogenesis, Inc. Announces Acquisition of NanoMatrix, Inc.
5. Organogenesis Debuts Educational Campaign for Sufferers of Chronic Leg and Foot Ulcers
6. Enerkem Named an Emerging Cleantech Leader in Canada
7. China Biologic Named to Forbes Magazines Fifth Annual List of Asias 200 Best Under a Billion
8. Neogen Again Named to Forbes List of Best Small Companies
9. OncoGenex Pharmaceuticals CEO Named Canadas Pacific Ernst & Youngs Entrepreneur Of The Year(R) in the Health Sciences Category
10. Advanced Health Media Named to 2009 InformationWeek 500 List of Top Technology Innovators Across America
11. Precision Therapeutics Named to Inc. Magazines List of Fastest Growing Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... 23, 2017  GlobeImmune, Inc. today announced it has ... of 12,835,490 shares of its common stock to NantCell, ... connection with the sale of its common stock, NantCell ... issue to GlobeImmune 200,000 shares, an estimated $2.0 million ... "We are pleased to enter into this strategic agreement ...
(Date:3/23/2017)... March 23, 2017 NetworkNewsWire Editorial Coverage  ... Cancer ... significant strain on health care systems, in terms of costs ... so too does the development of innovative and efficient therapies ... Among the many types of cancer treatments, a growing number ...
(Date:3/23/2017)... ... March 23, 2017 , ... Advanced Polymer Monitoring Technologies ... Dr. Sigmund “Sig” Floyd as Vice President ? Global Business Development. Dr. Floyd ... , “Dr. Floyd’s career has spanned 30 years in the chemicals and equipment ...
(Date:3/22/2017)... 2017  UBM and the Massachusetts Medical Device ... partnership and the third annual Massachusetts Medtech Week. Massachusetts ... st Annual MassMEDIC Conference held in conjunction ... 2017. MassMEDIC will feature a ... and CEO, Scott Whitaker , at its ...
Breaking Biology Technology:
(Date:2/27/2017)... --  Strategic Cyber Ventures , the industry,s first cybersecurity ... million investment in  Polarity , the first commercial human ... based and is led by cybersecurity veterans Tom ... Gula , also a longtime cybersecurity veteran and founder ... A round of funding. This new funding will be ...
(Date:2/21/2017)... Der weltweite Biobanking-Sektor wird bis ... Gespräch mit mehr als 50 Vertretern aus verschiedenen Branchen wurde ... um diese Prognose zu realisieren. ... Zu den Schwierigkeiten ... Mittel für die Biobank, die Implementierung Zeit sparender Technologien, ...
(Date:2/10/2017)... Research and Markets has announced the addition of ... Commercial Aspects" to their offering. ... Biomarkers play an important ... selection of treatment as well for monitoring the results. There ... modern medicine. Biochip/microarray technologies and next generation sequencing are also ...
Breaking Biology News(10 mins):